"The Saint John's Cancer Institute at Providence Saint John’s Health Center is a cancer research institute dedicated to the understanding and curing of cancer. Our mission is accomplished through innovative clinical and laboratory research and the education of the next generation of surgical oncologists and scientists."

During the past decade, John Wayne Cancer Institute at Providence Saint John's Health Center conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Wayne Cancer Institute at Providence Saint John's Health Center" #1 sponsor was "Saint John's Cancer Institute" with 7 trials, followed by "Acrotech Biopharma Inc." with 2 trials sponsored, "Blue Earth Diagnostics" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Cancer Insight, LLC" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Wayne Cancer Institute at Providence Saint John's Health Center" #1 collaborator was "Axis Clinicals Limited" with 2 trials as a collaborator, "Precision For Medicine" with 2 trials as a collaborator, "CancerLife" with 1 trials as a collaborator, "Elios Therapeutics, LLC" with 1 trials as a collaborator and "Healthy Platforms, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "John Wayne Cancer Institute at Providence Saint John's Health Center" are "Cancer" (4 trials), "Caregivers" (3 trials), "Brain Metastases" (2 trials), "Glioblastoma" (2 trials) and "Glioblastoma Multiforme" (2 trials). Many other conditions were trialed in "John Wayne Cancer Institute at Providence Saint John's Health Center" in a lesser frequency.

Most popular intervention types in "John Wayne Cancer Institute at Providence Saint John's Health Center" are "Drug" (14 trials), "Other" (5 trials), "Biological" (3 trials), "Device" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "18F fluciclovine" (2 trials), "CancerLife" (2 trials), "Nivolumab" (2 trials), "Pembrolizumab" (2 trials) and "Atazanavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "John Wayne Cancer Institute at Providence Saint John's Health Center" are 23 trials for "All" genders.

Currently, there are NaN active trials in "John Wayne Cancer Institute at Providence Saint John's Health Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in John Wayne Cancer Institute at Providence Saint John's Health Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in John Wayne Cancer Institute at Providence Saint John's Health Center, 6 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".